首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1737111

全球傳統創傷護理市場（按產品、應用、最終用戶和地區分類） (2026-2032)

Traditional Wound Care Market by Product (Gauze, Tape, Bandage, Cotton), Application (Chronic Wounds, Acute Wounds), End-User (Hospitals, Specialty Clinics, Home Healthcare), & Region for 2026-2032

出版日期: 2025年05月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

傳統創傷護理市場評估（2026-2032）

人們對先進創傷護理產品的認知度不斷提升，推動了傳統創傷護理市場規模的成長。根據 Verified Market Research 分析師預測，全球傳統創傷護理市場規模預計將從 2024 年的約 56.4 億美元成長至 2032 年的 74.5 億美元。

傳統創傷護理市場的快速擴張主要是由於慢性傷口的盛行率不斷上升，刺激了對有效傷口管理解決方案的需求，預計從 2026 年到 2032 年，複合年成長率將達到 3.54%。

傳統創傷護理市場定義/概述

傳統創傷護理是指用於治療和管理傷口的方法和產品，包括敷料、繃帶和局部藥膏。這種方法通常用於輕微割傷、擦傷和手術傷口，透過保濕提供必要的保護，形成一道防感染的屏障，並促進傷口癒合。各種技術，包括濕敷、乾敷和紗布敷料，都可用於促進傷口癒合，同時預防創傷護理護理併發症。

全球範圍內慢性傷口的日益增多，使得有效傷口管理的重要性日益凸顯。人口老化、糖尿病和肥胖症發病率飆升，以及人們對正確創傷護理實踐的認知不斷提高等因素，正在推動傳統創傷護理市場的成長。此外，產品配方的改進和創新技術的整合預計將顯著促進市場擴張。

我們的報告包含可操作的數據和前瞻性的分析，可協助您制定宣傳方案、建立商業計劃、組織簡報或撰寫提案。

慢性傷口的日益普及如何影響傳統創傷護理市場的成長？

慢性傷口的日益普遍被認為是影響傳統創傷護理市場成長的關鍵因素。糖尿病、血管疾病和人口老化等因素正在增加導致傷口癒合緩慢的疾病的發生率。隨著患有此類慢性疾病的患者人數不斷增加，對有效的傷口管理解決方案的需求也日益成長。世界衛生組織 (WHO) 預測，到 2045 年，糖尿病患者人數將從 2014 年的 4.22 億增加到 6.29 億，預計傳統創傷護理產品的需求將大幅成長。

因此，傳統的創傷護理產品被更頻繁地用於滿足這些需求，從而增加了市場規模。透過適當的創傷護理持續關注改善患者結果也反映在市場動態中，這推動了傳統方法和新技術的採用。

隨著先進創傷護理技術的日益普及，傳統創傷護理市場面臨哪些限制？

隨著先進創傷護理技術的日益普及，傳統創傷護理市場正面臨許多限制。向生物活性敷料和負壓創傷護理等更先進、更專業的產品轉變，被視為對傳統創傷護理方法的潛在挑戰。

隨著醫療保健提供者採用這些創新解決方案，傳統方法可能會被取代，從而限制市場成長。此外，醫療機構的預算限制更青睞可能更有效的先進創傷護理產品。因此，在技術進步日益主導的競爭格局中，傳統創傷護理產品可能難以維持市場佔有率。

Increasing awareness of advanced wound care products is driving the market size of the traditional wound care market. According to the analyst from Verified Market Research, the Traditional Wound Care Market is estimated to reach a valuation of USD 7.45 Billion By 2032 over the forecast subjugating around USD 5.64 Billion valued in 2024.

The rapid expansion of the traditional wound care market is primarily driven by the rising prevalence of chronic wounds, which is increasing the demand for effective wound management solutions. It enables the market to grow at a CAGR of 3.54% from 2026 to 2032.

Traditional Wound Care Market: Definition/ Overview

Traditional wound care refers to the methods and products used to treat and manage wounds, which include dressings, bandages, and topical ointments. This approach is often utilized for minor cuts, abrasions, and surgical wounds, providing essential protection and promoting healing through moisture retention and barrier formation against infections. Various techniques, such as wet-to-dry dressings and gauze applications, are employed to facilitate the healing process while preventing complications associated with wound care.

Increasing emphasis is placed on the importance of effective wound management as the global incidence of chronic wounds rises. The growth of the traditional wound care market is supported by factors such as an aging population, a surge in diabetes and obesity rates, and a growing awareness of proper wound care practices. Furthermore, advancements in product formulations and the integration of innovative technologies are expected to contribute significantly to market expansion.

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How is the Increasing Prevalence of Chronic Wounds Impacting the Growth of the Traditional Wound Care Market?

The increasing prevalence of chronic wounds is being recognized as a significant driver affecting the growth of the traditional wound care market. Factors such as diabetes, vascular diseases, and an aging population are contributing to a higher incidence of conditions that result in slow-healing wounds. As the number of individuals suffering from these chronic conditions rises, the demand for effective wound management solutions is being escalated. With the World Health Organization projecting the number of people with diabetes to rise from 422 million in 2014 to 629 million by 2045, the demand for traditional wound care products is expected to surge.

Consequently, traditional wound care products are being utilized more frequently to address these needs, thus leading to an expansion in market size. The ongoing focus on improving patient outcomes through proper wound care is also being reflected in the market dynamics, enhancing the adoption of traditional methods alongside newer technologies.

What Restraints are Being Faced by the Traditional Wound Care Market Due to the Rising Availability of Advanced Wound Care Technologies?

Various restraints are being faced by the traditional wound care market due to the rising availability of advanced wound care technologies. The shift toward more sophisticated and specialized products, such as bioactive dressings and negative pressure wound therapy, is being observed as a potential challenge for traditional wound care methods.

As healthcare providers increasingly adopt these innovative solutions, traditional approaches are being overshadowed, which may limit market growth. Additionally, budget constraints in healthcare facilities are leading to a preference for advanced wound care products, which are often perceived as more effective. As a result, traditional wound care products may struggle to maintain their market share in a competitive landscape increasingly dominated by technological advancements.

Category-Wise Acumens

What is the Dominating Product Segment Within the Traditional Wound Care Market?

According to VMR analyst, the dominating product segment within the traditional wound care market is gauze, which is widely utilized due to its versatility and effectiveness in wound management. Gauze products are preferred for their ability to absorb exudate while allowing airflow to the wound, which is essential for the healing process.

Various types of gauze, including sterile and non-sterile options, are being offered to cater to diverse clinical needs. The widespread availability and cost-effectiveness of gauze are also contributing to its popularity among healthcare providers. As a result, gauze is being recognized as a staple in both hospital and home healthcare settings, further solidifying its position as the leading product in the market.

Why Chronic Wounds is Experiencing Rapid Growth in the Traditional Wound Care Market?

According to VMR analyst, the chronic wounds segment is experiencing rapid growth in the traditional wound care market, which are increasingly being recognized for their complex management requirements. Conditions such as diabetes and venous ulcers are leading to a rise in chronic wounds, necessitating effective treatment solutions.

As the prevalence of these conditions increases, the demand for products specifically designed for chronic wound care is being amplified. Innovative treatment options and enhanced education regarding chronic wound management are also contributing to this growth. Consequently, healthcare providers are focusing on developing tailored care strategies, ensuring that the chronic wound application sub-segment remains at the forefront of market expansion.

Country/Region-wise Acumens

What Factors Contribute to North America's Dominance in the Traditional Wound Care Market?

According to VMR analyst, various factors are contributing to North America's dominance in the traditional wound care market, with a robust healthcare infrastructure being a significant element. High healthcare expenditure in the region is facilitating access to advanced medical technologies and wound care products.

Additionally, the increasing prevalence of chronic wounds, driven by an aging population and rising rates of diabetes, is being observed in North America, creating a strong demand for effective wound management solutions. According to the U.S. Census Bureau, by 2032, all baby boomers will be older than 65, expanding the size of the older population so that 1 in every 5 residents will be of retirement age. The number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060.

Comprehensive reimbursement policies are also being implemented, ensuring that wound care products are widely accessible to patients. Consequently, these factors are being recognized as crucial drivers of market growth, solidifying North America's position as a leader in the traditional wound care market.

How is the Asia Pacific Region Experiencing Rapid Growth in the Traditional Wound Care Market?

According to VMR analyst, the Asia Pacific region is experiencing rapid growth in the traditional wound care market due to several key factors, including a rising population and increasing awareness of healthcare standards. Economic development in countries such as China and India are leading to improvements in healthcare access and infrastructure, which are fostering greater adoption of wound care products.

Additionally, the growing prevalence of lifestyle-related chronic diseases is resulting in a higher incidence of wounds requiring management. According to the IDF Diabetes Atlas, the number of adults with diabetes in the Western Pacific region was approximately 162.6 million in 2019 and is projected to rise to 260 million by 2045, representing a significant increase of about 27%.

Government initiatives aimed at enhancing healthcare services are also being implemented, thereby supporting market growth. As a result, the Asia Pacific region is being positioned as a rapidly expanding market within the traditional wound care sector, with significant potential for future developments.

Competitive Landscape

The Traditional Wound Care Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the traditional wound care market include:

3M

Braun Melsungen AG

Coloplast A/S

Convatec Group plc

Dermarite Industries LLC.

Deroyal Industries, Inc.

Hollister Incorporated

Integra Lifesciences Holdings Corporation

Johnson & Johnson Private Limited

Medtronic plc.

Molnlycke Health Care Ab

Paul Hartmann AG

Smith & Nephew plc.

Latest Developments

In April 2024, M Health Care's innovative 3M(TM) Veraflo(TM) Therapy, with both 3M(TM) Veraflo(TM) Cleanse Choice Complete(TM) Dressing and 3M(TM) V.A.C. Veraflo Cleanse Choice(TM) Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue, and wound debris. This reduces the number of surgical debridements required while promoting granulation tissue formation and creating an environment that promotes wound healing.

1 INTRODUCTION OF GLOBAL TRADITIONAL WOUND CARE MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL TRADITIONAL WOUND CARE MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL TRADITIONAL WOUND CARE MARKET, BY PRODUCT

5.1 Overview
5.2 Gauze
5.3 Tape
5.4 Bandage
5.5 Cotton

6 GLOBAL TRADITIONAL WOUND CARE MARKET, BY APPLICATION

6.1 Overview
6.2 Chronic Wounds
6.3 Acute Wounds

7 GLOBAL TRADITIONAL WOUND CARE MARKET, BY END-USER

7.1 Overview
7.2 Hospital
7.3 Clinic
7.4 Home Healthcare
7.5 Others

8 GLOBAL TRADITIONAL WOUND CARE MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Middle East and Africa
- 8.5.2 South America

9 GLOBAL TRADITIONAL WOUND CARE MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 3M
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Braun Melsungen AG
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Coloplast A/S
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Convatec Group plc
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Dermarite Industries LLC.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Deroyal Industries, Inc.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Hollister Incorporated
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Integra Lifesciences Holdings Corporation
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Johnson & Johnson Private Limited
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Medtronic plc.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.11 Molnlycke Health Care Ab
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments
10.12 Paul Hartmann AG
- 10.12.1 Overview
- 10.12.2 Financial Performance
- 10.12.3 Product Outlook
- 10.12.4 Key Developments
10.13 Smith & Nephew plc.
- 10.13.1 Overview
- 10.13.2 Financial Performance
- 10.13.3 Product Outlook
- 10.13.4 Key Developments